|
|||||||
|
|
||||||
Molecular Pathology
Laboratory |
|||||||
Patients' information |
Doctors' information |
Students' Material | Contact us | ||||
TESTS OFFERED
![]() |
Breast cancer |
Colorectal cancer | Ewing's sarcoma | Oligodendroglioma | Cytogenetics |
Diagnostic Division Breast cancer |
![]() |
|
|
|
|
Fluorescent in situ |
|
|
![]()
|
||
|
BRCA1 and BRCA2 Sequencing
|
![]() Our laboratory offers a level approach for sequencing BRCA1 and BRCA2 genes. To offer a comprehensive coverage we also employ MLPA for exon copy number determination. In Kuwait, which is composed of young population, 40% of breast cancers inflict patients younger than 45 years of age. Of interest is that 70% of these are oestrogen receptor positive. This is in contrast to beast cancers with defective BRCA1 or BRCA2 genes, which are usually oestrogen receptor negative. Our laboratory is currently conducting a population screening to identify breast cancer predisposing genes in our unique population. The availability of large consanguineous families with several affected individuals gives us a unique opportunity to do this. Standard operating protocol appeared here and on request"Age-dependent penetrance of different germline mutations in BRCA1 gene"
|
|
||
We now offer exome sequencing for breast cancer at a fraction of the cost
of BRCA1 and 2 genes. Please contact us for detail |
||
Copyright al-mulla.org© |